UBS Group’s Innovator US Equity Accelerated Plus ETF April XTAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-903
Closed -$37.4K – 11119
2026
Q1
$37.4K Buy
903
+2
+0.2% +$82 ﹤0.01% 7552
2025
Q4
$36.7K Buy
901
+642
+248% +$25.7K ﹤0.01% 7396
2025
Q3
$10.3K Sell
259
-3,209
-93% -$125K ﹤0.01% 8551
2025
Q2
$133K Buy
3,468
+1,247
+56% +$45K ﹤0.01% 7006
2025
Q1
$79K Buy
+2,221
New +$77.9K ﹤0.01% 7232
2024
Q4
– Sell
-322
Closed -$10.8K – 10485
2024
Q3
$10.8K Buy
+322
New +$10.5K ﹤0.01% 7708
2024
Q2
– Sell
-82
Closed -$2.54K – 10194
2024
Q1
$2.54K Buy
82
+53
+183% +$1.63K ﹤0.01% 7883
2023
Q4
$878 Buy
+29
New +$843 ﹤0.01% 8487
2023
Q1
– Sell
-1,438
Closed -$35.3K – 10492
2022
Q4
$35.3K Buy
1,438
+32
+2% +$791 ﹤0.01% 7079
2022
Q3
$32K Buy
1,406
+1,229
+694% +$31.6K ﹤0.01% 6807
2022
Q2
$4K Sell
177
-175
-50% -$4.65K ﹤0.01% 9151
2022
Q1
$10K Buy
+352
New +$10K ﹤0.01% 8449

Other funds holding XTAP

UBS Group's XTAP Position: Q2 2026 in Review

UBS Group sold out of Innovator US Equity Accelerated Plus ETF April (XTAP) in Q2 2026, closing a stake of 903 shares — an estimated $37.4K sold.

UBS Group first reported a position in XTAP in Q1 2022 and held it in 12 quarters. The position peaked at $133K in Q2 2025. 13 funds tracked by Wall St. Rank hold XTAP as of Q2 2026.

  • UBS Group reported no remaining Innovator US Equity Accelerated Plus ETF April position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 903 Innovator US Equity Accelerated Plus ETF April shares in Q2 2026, an estimated $37.4K.
  • UBS Group first reported a position in Innovator US Equity Accelerated Plus ETF April in Q1 2022 and held it in 12 quarters.
  • UBS Group's Innovator US Equity Accelerated Plus ETF April position peaked at $133K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF April as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.